Literature DB >> 17898864

Phosphorylation at carboxyl-terminal S373 and S375 residues and 14-3-3 binding are not required for mouse p53 function.

Ming Kei Lee1, Kanaga Sabapathy.   

Abstract

gamma-Irradiation-mediated ataxia telangiectasia mutated (ATM)-dependent dephosphorylation of serine 376 (S376) at the carboxyl terminus of human p53 results in the exposure of the 14-3-3 consensus-binding site, which includes serine 378 (S378). 14-3-3 binding potentiates p53's DNA-binding ability and causes G(1) arrest. Moreover,endoplasmic reticulum stress-mediated S376 phosphorylation was shown to localize human p53 in the cytoplasm. Although many functions are conserved between human and mouse p53, the functional relevance of S376 and S378 mouse equivalents is not clear. We report here that gamma-irradiation does not lead to 14-3-3 binding to mouse p53. Mouse p53 mutants, such as S373A/D (the equivalent of human S376), S375A/D (the equivalent of human S378), and combinatorial double mutants, were not impaired in their ability to transactivate p53-dependent target genes and were capable of inducing G(1) arrest as efficiently as wild-type p53. Consistently, all mutant p53s were as potent as wild-type mouse p53 in inhibiting cellular colony formation. Furthermore, mouse S373A/D mutants were not defective in cytoplasmic localization in response to endoplasmic reticulum stress. Together, the data suggest that despite a high homology with human p53, neither phosphorylation status at S373 and S375 nor 14-3-3 binding may be a critical event for mouse p53 to be functional.

Entities:  

Keywords:  14-3-3 binding; S373; S375; mouse p53; phosphorylation

Mesh:

Substances:

Year:  2007        PMID: 17898864      PMCID: PMC1993853          DOI: 10.1593/neo.07511

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  25 in total

1.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

Review 2.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

3.  Evaluation of the combined effect of p53 codon 72 polymorphism and hotspot mutations in response to anticancer drugs.

Authors:  Faina Vikhanskaya; Mobin M Siddique; Ming Kei Lee; Massimo Broggini; Kanaga Sabapathy
Journal:  Clin Cancer Res       Date:  2005-06-15       Impact factor: 12.531

Review 4.  Multiple roles of the tumor suppressor p53.

Authors:  Jill Bargonetti; James J Manfredi
Journal:  Curr Opin Oncol       Date:  2002-01       Impact factor: 3.645

5.  JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression.

Authors:  E Passegué; E F Wagner
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

6.  Substitutions that compromise the ionizing radiation-induced association of p53 with 14-3-3 proteins also compromise the ability of p53 to induce cell cycle arrest.

Authors:  E S Stavridi; N H Chehab; A Malikzay; T D Halazonetis
Journal:  Cancer Res       Date:  2001-10-01       Impact factor: 12.701

7.  14-3-3 sigma positively regulates p53 and suppresses tumor growth.

Authors:  Heng-Yin Yang; Yu-Ye Wen; Chih-Hsin Chen; Guillermina Lozano; Mong-Hong Lee
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  Phosphorylation of serine 18 regulates distinct p53 functions in mice.

Authors:  Hayla K Sluss; Heather Armata; Judy Gallant; Stephen N Jones
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3beta.

Authors:  LiKe Qu; Shirley Huang; Dionissios Baltzis; Ana-Maria Rivas-Estilla; Olivier Pluquet; Maria Hatzoglou; Costas Koumenis; Yoichi Taya; Akihiko Yoshimura; Antonis E Koromilas
Journal:  Genes Dev       Date:  2004-01-26       Impact factor: 11.361

10.  Mutant loxP vectors for selectable marker recycle and conditional knock-outs.

Authors:  H Arakawa; D Lodygin; J M Buerstedde
Journal:  BMC Biotechnol       Date:  2001-09-26       Impact factor: 2.563

View more
  4 in total

1.  Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo.

Authors:  M K Lee; W M Tong; Z Q Wang; K Sabapathy
Journal:  Cell Death Differ       Date:  2010-07-30       Impact factor: 15.828

2.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

3.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

4.  14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers.

Authors:  Sridharan Rajagopalan; Agnes M Jaulent; Mark Wells; Dmitry B Veprintsev; Alan R Fersht
Journal:  Nucleic Acids Res       Date:  2008-09-23       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.